Prof. Dr. med. Peter Hohenberger

Prof. Dr. med. Peter Hohenberger is a highly accomplished doctor specializing in visceral and vascular surgery, surgical oncology, and thoracic surgery. With 43 years of experience, he has established himself as a leading expert. Dr. Hohenberger studied human medicine at the University of Erlangen and obtained his license for medical practice. He further pursued visceral and vascular surgery specialization at the University of Heidelberg, followed by a habilitation and teaching license. Dr. Hohenberger has additional qualifications in special surgical oncology, thoracic surgery, and surgical intensive care. Notably, Dr. Hohenberger has held senior positions at the Department of Surgery and served as a professor of surgical oncology at the renowned Charite University Hospital in Berlin. In 2022, he assumed the role of Head of the Department of Thoracic Surgery at the University Hospital Mannheim in Germany. Dr. Hohenberger's expertise is widely recognized, as he is listed in the FOCUS top lists of doctors for his exceptional treatment of tumors of the digestive tract, bone, soft tissue, and lung. With over 360 scientific publications, Dr. Hohenberger's research contributions have significantly advanced our understanding and treatment of various cancers. His work includes studies on preoperative hyperthermia combined with radiochemotherapy in rectal cancer, comprehensive cancer predisposition testing, and guiding therapeutic decisions for rare cancers. Dr. Hohenberger is also actively involved in leading professional organizations, serving as the chairman of the soft tissue and bone sarcoma group at the European Organisation for Research and Treatment of Cancer and chair of the interdisciplinary working party on sarcoma of the German Cancer Society. In summary, Prof. Dr. med. Peter Hohenberger's extensive experience, specialization in multiple disciplines, and groundbreaking research make him a highly respected and sought-after doctor in surgical oncology and thoracic surgery. His expertise, leadership roles, and numerous scientific publications demonstrate his dedication to advancing cancer treatment and patient outcomes.